| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |